FitLife Brands, Inc. (FTLF) Stock

FitLife Brands, Inc. (FTLF) is a Healthcare stock trading at $9.91 (as of 2026-08-21), with a market capitalization of $93.07M and a trailing P/E of 15.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

FitLife Brands, Inc. develops and sells nutritional supplements and related products for health and fitness customers in the United States and internationally. Its product line includes weight-loss, general health, and sports nutrition offerings marketed under brands such as NDS Nutrition and PMD Sports through franchised and retail channels, including specialty, mass, and online.

Understand FitLife Brands, Inc.: how it makes money

FitLife Brands sells nutritional supplements, including weight loss, general health, and sports nutrition products, mainly through wholesale and online channels, with part of its online business coming from subscription customers.

Online sales include a meaningful subscription component (customers on subscription are 30% of online revenue), so subscriber engagement and retention can support more recurring demand, while wholesale sales provide an additional non subscription channel.

Revenue by segment (latest quarter)
Wholesale	$0.0B
Online	$0.0B

Business quality (Solid): The company has subscription and channel KPIs that can help explain demand drivers, but the latest-quarter revenue figures in this dataset are extremely small (and rounded), which reduces how informative short-term trend checks may be.

Valuation: At 19× earnings, FTLF trades 12% above the Pharmaceutical Products average (17×). Note: one-time items can distort reported P/E.

Bull case

Subscription-led online demand signal: Active Subscribers are reported as 104000, and subscription customers represent 30% of online revenue.
Multiple go-to-market channels: Segment revenue is split between Wholesale and Online, indicating the business is not purely dependent on one distribution route.
Ongoing Amazon distribution footprint: Amazon product listings actively being sold for Erwin Naturals are reported as 116, and subscriber counts for Erwin products are tracked.

Bear case

Potential channel volatility and measurement limits: Several Amazon-related revenue KPIs are shown as 0.0 in this dataset, so changes in how sales are attributed or captured could make performance harder to interpret.
Short-term signal risk: Reported latest-quarter revenue is extremely small in the dataset (rounded), which can make KPI moves and margins harder to judge as durable trends.
Concentration in specific brand and listing activity: Some KPIs focus on Erwin Naturals and Amazon listings, so brand performance and listing availability can materially affect outcomes.

Valuation — source: SEC EDGAR (first-party)
Price	$9.91
Market Cap	$93.07M
P/E Ratio	15.5
EV / EBITDA	7.4
Price / Book	1.96
Price / Sales	1.59
FCF Yield	9.5%
DCF Value (model)	$13.82
DCF Upside vs Price	39.5%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$81.46M
Net Margin	7.8%
Revenue Growth (YoY)	64.6%
EPS Growth (YoY)	10.5%
FCF Growth (YoY)	414.2%

Financial Health — source: SEC EDGAR
Altman Z-Score	2.26 (grey)

Valuation vs Sector & Industry
Stock P/E	15.5
Sector P/E (Healthcare)	21.7
Industry P/E (Pharmaceutical Products)	17.2
vs Sector	-28.5%
vs Industry	-9.5%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	VANGUARD GROUP INC ($3.34M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Dayton Robert Judd
Employees	39
Country	US
IPO Date	2007-11-02

Related Companies (Business model: Branded Consumer (CPG, Staples, Beauty, Alcohol, Pet, Nicotine); 8 closest by market cap; US-domiciled)

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.